Net (Loss) Income Per Share (Tables)

3 Months Ended

Mar. 31, 2013

Earnings Per Share [Abstract]

Reconciliation Of The Numerator And Denominator Of Basic And Diluted Net (Loss) Income Per Share

The following is a reconciliation of the numerator and denominator of basic and diluted net income (loss) per share (in thousands, except per share data):

	Three Months Ended March 31,
	2013		2012
Numerator:
Net income (loss) attributable to Endo Health Solutions Inc. common stockholders	$	15,349	$	(87,345	)
Denominator:
For basic per share data—weighted average shares	111,216		117,052
Dilutive effect of common stock equivalents	1,952		—
Dilutive effect of 1.75% Convertible Senior Subordinated Notes and warrants	21		—
For diluted per share data—weighted average shares	113,189		117,052
Basic net income (loss) per share attributable to Endo Health Solutions Inc.	$	0.14	$	(0.75	)
Diluted net income (loss) per share attributable to Endo Health Solutions Inc.	$	0.14	$	(0.75	)

Reconciliation Of Maximum Potential Dilution Of Shares Currently Excluded From The Calculation Of Diluted Net Income Per Share

The following reconciliation shows the maximum potential dilution of shares currently excluded from the calculation of diluted net income (loss) per share for the three months ended March 31, 2013 and 2012 (in thousands):

	Three Months Ended March 31,
	2013	2012
Weighted average shares excluded:
1.75% Convertible senior subordinated notes due 2015 and warrants(1)	25,972	25,993
Employee stock-based awards	4,422	3,083
	30,394	29,076

__________

(1) Amounts represent the incremental potential total dilution that could occur if our Convertible Notes and warrants were converted to shares of our common stock.